In recent trading session, Acutus Medical Inc (NASDAQ:AFIB) saw 2.53 million shares changing hands at last check today with its beta currently measuring 0.19. Company’s recent per share price level of $0.22 trading at $0.03 or 17.02% at last check today assigns it a market valuation of $6.34M. That most recent trading price of AFIB’s stock is at a discount of -790.91% from its 52-week high price of $1.96 and is indicating a premium of 27.27% from its 52-week low price of $0.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.24 million shares which gives us an average trading volume of 256.13K if we extend that period to 3-months.
For Acutus Medical Inc (AFIB), analysts’ consensus is at an average recommendation of a Hold while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.62 in the current quarter.
Acutus Medical Inc (NASDAQ:AFIB) trade information
Upright in the green today for gaining 17.02%, iAcutus Medical Inc’s shares saw a change of -81.17% in year-to-date performance and have moved -1.55% in past 5-day. Acutus Medical Inc (NASDAQ:AFIB) showed a performance of -62.91% in past 30-days. Number of shares sold short was 0.25 million shares which calculate 4.38 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $0.50 to the stock, which implies a rise of 56.0% to its recent value today. Analysts have been projecting $0.50 as a low price target for the stock while placing it at a high target of $0.50. It follows that stock’s current price would drop -127.27% in reaching the projected high whereas dropping to the targeted low would mean a loss of -127.27% for stock’s current value.
Acutus Medical Inc (AFIB) estimates and forecasts
This year revenue growth is estimated to rise 27.10% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $6.63 million for the same. And 1 analysts are in estimates of company making revenue of $6.81 million in the next quarter that will end on Mar 2024. Company posted $4.96 million and $4.17 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 33.60% while estimating it to be 63.30% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 5.40% during past 5 years.
Acutus Medical Inc is more likely to be releasing its next quarterly report on November 14 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.